Depression is one of the most misunderstood and under-treated conditions in India. "Just be more positive," "count your blessings" or "pray harder" are well-meaning but fundamentally unhelpful responses to clinical depression — which involves measurable changes in brain chemistry, neural circuitry and the stress hormone system. It is not a character weakness, a choice, or something people can simply will themselves out of. This comprehensive guide explains what depression really is, how to recognise it, why it develops, what it does to people's lives, and — most importantly — how it can be effectively treated.
Major Depressive Disorder (MDD), commonly referred to as clinical depression, is a medical condition characterised by a persistently depressed mood or a marked loss of interest or pleasure in almost all activities, lasting at least two weeks, and causing significant impairment in daily functioning. It is not the same as:
Clinical depression is a biological condition. It involves changes in neurotransmitter systems (serotonin, norepinephrine, dopamine), dysregulation of the HPA axis (the body's stress hormone system), inflammatory processes, and structural changes in brain regions including the hippocampus and prefrontal cortex. These are measurable biological changes — not moral failings.
Depression is a major public health problem in India, yet dramatically under-recognised and under-treated:
Depression is not one-size-fits-all. Several distinct depressive disorders exist, each with different presentations and treatment implications.
The most common form. Episodes last at least two weeks and involve at least five of the nine diagnostic symptoms. MDD can be mild, moderate or severe, and can be a single episode or recurrent.
A chronically low-grade depressive mood lasting at least two years. Symptoms are less intense than MDD but their chronic nature makes them particularly disabling. People with dysthymia often describe feeling like they have "always been this way" and fail to seek help.
Depressive episodes that occur as part of Bipolar Disorder (which also includes periods of elevated or manic mood). Bipolar depression is often misdiagnosed as unipolar depression, which is important because the treatment differs significantly — antidepressants alone can trigger mania in bipolar disorder.
Depression that follows a seasonal pattern — most commonly occurring in winter months with less sunlight exposure. While less prevalent in tropical India, it does occur, particularly in northern states with colder, cloudier winters.
Depression occurring after childbirth, affecting approximately 22% of mothers in India — significantly higher than the global average of 10–15%. Cultural pressures, lack of social support and hormonal changes all contribute. Often unrecognised and untreated in India due to stigma and the expectation that new motherhood should be joyful.
Severe depression accompanied by psychotic symptoms such as hallucinations or delusions. Requires more intensive treatment including antipsychotic medication alongside antidepressants.
Depression that does not respond to at least two adequate courses of antidepressant treatment. Requires specialist management including augmentation strategies or newer interventions such as ketamine therapy or TMS (Transcranial Magnetic Stimulation).
Depression affects how you feel, think, and behave across multiple dimensions. Recognising these symptoms — especially the less obvious ones — is the first step to getting help.
In India and many Asian cultures, depression frequently presents somatically — primarily as physical symptoms including chronic pain, fatigue, headaches and digestive problems — rather than the emotional symptoms more familiar in Western clinical contexts. This "masked depression" or "somatised depression" often leads people to seek treatment for physical symptoms without the underlying depression being recognised or addressed. This contributes significantly to India's massive treatment gap.
Depression does not have a single cause. It arises from the interaction of biological vulnerability, psychological factors and environmental stressors — the biopsychosocial model.
Untreated depression has severe consequences that extend far beyond mood. It is a leading cause of disability worldwide and the second leading cause of years lived with disability in India.
Depression impairs concentration, decision-making, motivation and energy. It is a leading cause of absenteeism and presenteeism (being physically present but unable to function). Students with depression show significantly lower academic performance, higher dropout rates, and higher rates of exam failure. The economic cost of lost productivity due to depression and anxiety in India is estimated at $1.03 trillion between 2012 and 2030 (WHO).
Depression causes social withdrawal, reduced communication, irritability and emotional unavailability — all of which damage relationships. Divorce rates are significantly higher in couples where one partner has untreated depression. Friendships and family ties fray as depressed individuals withdraw and others do not know how to respond.
Depression significantly worsens outcomes for virtually all physical health conditions. People with depression and heart disease have twice the mortality rate of heart patients without depression. Depression is associated with increased risk of type 2 diabetes, stroke, obesity and immune dysfunction. The relationship is bidirectional — physical illness causes depression, and depression worsens physical illness.
Depression is the single largest risk factor for suicide. Approximately 15% of people with untreated severe depression die by suicide. In India, where suicide rates are among the highest globally for young adults, early identification and treatment of depression is literally life-saving. If you or someone you know has thoughts of suicide, contact iCall: 9152987821 or Vandrevala Foundation: 1860-2662-345.
Depression commonly co-occurs with anxiety disorders (50–60% comorbidity rate), substance use disorders, OCD, eating disorders and personality disorders. Each comorbidity complicates treatment and worsens outcomes if not addressed.
Depression is diagnosed by a qualified mental health professional through clinical assessment. There is no blood test or brain scan that definitively diagnoses depression (though tests may be done to rule out physical causes). The assessment involves:
Depression is highly treatable. With appropriate care, 70–80% of people experience meaningful improvement. Treatment should be matched to severity and individual circumstances.
CBT is the most evidence-based psychological treatment for depression. It targets the three components that maintain depression: negative thinking patterns, behavioural withdrawal (stopping activities that used to bring pleasure), and problematic coping strategies. A typical course is 12–20 weekly sessions. CBT's effects are durable — relapse rates are significantly lower after CBT than medication alone. The Mentis app provides CBT-based conversations available 24/7.
A powerful and often underused first-line treatment: deliberately scheduling enjoyable and meaningful activities to break the inactivity-low mood cycle. Depression causes withdrawal from activities, which reduces positive reinforcement and deepens low mood. Behavioural activation directly reverses this cycle and is as effective as full CBT for mild-moderate depression.
IPT focuses on improving the quality of relationships and addressing interpersonal difficulties — grief, role disputes, role transitions and interpersonal deficits — that trigger and maintain depression. IPT is particularly effective when depression has a clear interpersonal trigger such as bereavement or divorce, and has shown good efficacy in Indian populations.
MBCT combines mindfulness meditation with cognitive therapy principles. It is particularly effective for preventing relapse in people with recurrent depression — reducing relapse rates by approximately 43%. Particularly well-suited to Indian contexts given yoga and meditation's cultural accessibility.
SSRIs (selective serotonin reuptake inhibitors) — sertraline, escitalopram, fluoxetine — are the first-line medication for moderate to severe depression. They take 4–6 weeks to reach full effect. SNRIs (venlafaxine, duloxetine) are effective for depression with comorbid anxiety or pain. Mirtazapine is useful when insomnia and appetite loss are prominent features. TCAs (tricyclic antidepressants) are older medications still used when newer options fail. Medication is most effective when combined with therapy.
Never start, stop or change antidepressant dose without consulting a psychiatrist. Abrupt discontinuation causes withdrawal symptoms.
Meta-analyses consistently show that regular aerobic exercise (30–45 minutes, 4–5 times per week) is as effective as antidepressants for mild to moderate depression. Exercise increases BDNF (brain-derived neurotrophic factor), promotes hippocampal neurogenesis, reduces cortisol, and releases endorphins. It is underused as a first-line treatment despite compelling evidence.
These strategies are valuable alongside professional treatment and can provide meaningful relief for mild depression:
Seek professional help if:
Crisis support in India: iCall — 9152987821 | Vandrevala Foundation — 1860-2662-345 | NIMHANS Helpline — 080-46110007
Sadness is a normal emotional response to loss or disappointment that eases over time without significantly impairing daily functioning. Clinical depression involves persistent low mood or loss of interest lasting at least two weeks, with measurable changes in brain chemistry and significant impairment in work, relationships and daily life. It does not simply lift by "thinking positively".
Approximately 56 million Indians — about 4.5% of the population — have depression. 1 in 20 Indians suffers from it. Among 15–24 year olds, 14% report frequent depression. Despite this, more than 80% receive no treatment due to stigma, cost and shortage of professionals.
Key signs: persistent sadness or emptiness for more than two weeks, loss of interest in previously enjoyed activities, fatigue, sleep problems, weight changes, feelings of worthlessness, difficulty concentrating, and thoughts of death or suicide. In India, depression often presents as chronic pain, headaches or digestive complaints.
With appropriate treatment, 70–80% of people experience significant improvement, and many achieve full remission. Depression is recurrent — about 50% will have another episode — so ongoing self-care and sometimes maintenance therapy helps prevent relapse. It is very much a manageable condition with the right support.
The most effective treatment for moderate-severe depression is CBT combined with antidepressant medication (typically SSRIs). For mild depression, structured CBT self-help, behavioural activation and exercise are often sufficient. Treatment should be supervised by a qualified psychiatrist or psychologist.
Listen without judgment, validate their experience, and avoid minimising phrases. Offer practical support and gently encourage professional help. For crisis: iCall (9152987821) or Vandrevala Foundation (1860-2662-345). Apps like Mentis provide 24/7 evidence-based support while waiting for professional care.
If you or someone you know is having thoughts of suicide or self-harm, contact iCall India: 9152987821 (free, confidential) or Vandrevala Foundation: 1860-2662-345. You are not alone — help is available.